Jun Wang1, Kun Liu, Li Shen, Haiwei Wu, Hua Jing. 1. Department of Cardiothoracic Surgery, Jinling Hospital, Clinical Medicine School of Nanjing University, Nanjing, Jiangsu Province, China.
Abstract
BACKGROUND: Vascular smooth muscle cell (VSMC) proliferation plays an important role in the failure of autologous vein grafts. The c-myc gene activation is highly involved in the VSMC proliferation. In this study, we made an attempt to determine whether VSMC proliferation and vein graft restenosis could be attenuated by silencing the c-myc gene with small interference RNA (siRNA). METHODS: The effects of c-myc siRNA on VSMCs in vitro were examined both in cell proliferation and c-myc expression. Thirty-two Sprague-Dawley rats underwent autologous jugular vein to carotid artery reverse interposition grafting and were randomly divided in to four groups. Vein grafts were treated with pluronic gel or gel containing a scrambled siRNA or c-myc siRNA and the control group received no treatment. Intimal thickness of the vein grafts was evaluated at 3 wk after the surgery. RESULTS: In vitro, c-myc siRNA inhibited cell proliferation by 40%, reduced c-myc mRNA level by 70%, and c-myc protein level by 50% compared with the controls. In vivo, the c-myc siRNA treatment reduced intimal hyperplasia by 75%. CONCLUSIONS: Our data suggested that c-myc siRNA, when given immediately after the surgery, is an effective approach for the prevention of vein graft restenosis.
BACKGROUND: Vascular smooth muscle cell (VSMC) proliferation plays an important role in the failure of autologous vein grafts. The c-myc gene activation is highly involved in the VSMC proliferation. In this study, we made an attempt to determine whether VSMC proliferation and vein graft restenosis could be attenuated by silencing the c-myc gene with small interference RNA (siRNA). METHODS: The effects of c-myc siRNA on VSMCs in vitro were examined both in cell proliferation and c-myc expression. Thirty-two Sprague-Dawley rats underwent autologous jugular vein to carotid artery reverse interposition grafting and were randomly divided in to four groups. Vein grafts were treated with pluronic gel or gel containing a scrambled siRNA or c-myc siRNA and the control group received no treatment. Intimal thickness of the vein grafts was evaluated at 3 wk after the surgery. RESULTS: In vitro, c-myc siRNA inhibited cell proliferation by 40%, reduced c-myc mRNA level by 70%, and c-myc protein level by 50% compared with the controls. In vivo, the c-myc siRNA treatment reduced intimal hyperplasia by 75%. CONCLUSIONS: Our data suggested that c-myc siRNA, when given immediately after the surgery, is an effective approach for the prevention of vein graft restenosis.
Authors: Kevin W Southerland; Sarah B Frazier; Dawn E Bowles; Carmelo A Milano; Christopher D Kontos Journal: Transl Res Date: 2012-12-27 Impact factor: 7.012
Authors: Karina Schleimer; Jochen Grommes; Andreas Greiner; Houman Jalaie; Johannes Kalder; Stephan Langer; Thomas A Koeppel; Michael Jacobs; Maria Kokozidou Journal: J Vis Exp Date: 2012-11-11 Impact factor: 1.355
Authors: Christoph S Nabzdyk; Maggie C Chun; Hunter S Oliver-Allen; Saif G Pathan; Matthew D Phaneuf; Jin-Oh You; Leena K Pradhan-Nabzdyk; Frank W LoGerfo Journal: Biomaterials Date: 2014-01-04 Impact factor: 12.479
Authors: Kee-Won Lee; Piyusha S Gade; Liwei Dong; Zhaoxiang Zhang; Ali Mubin Aral; Jin Gao; Xiaochu Ding; Chelsea E T Stowell; Muhammad Umer Nisar; Kang Kim; Dieter P Reinhardt; Mario G Solari; Vijay S Gorantla; Anne M Robertson; Yadong Wang Journal: Biomaterials Date: 2018-07-26 Impact factor: 12.479